Bright Peak Therapeutics
Switzerland - BaselBiotechnology
Focus: Bright Peak Therapeutics is a Swiss biotech company specializing in engineered cytokines for immuno-oncology, focused on advanced solid tumors. The company operates as a publicly-traded entity with a lean, focused pipeline in early-stage development.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Bright Peak Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Bright Peak Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
BPT567
Advanced Solid TumorsClinical Trials (1)
NCT06779851A Study to Evaluate Safety and Tolerability of BPT567 in Patients With Advanced Solid Tumors
Phase 1Help build intelligence for Bright Peak Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.